Search research articles
Contact Us
Filters
Showing results (511-520 of 633) with videos related to
Page
of 64
Sort By:
European Journal of Radiology
|
October 8, 2023
Prognostic value of baseline MRI features in patients treated with thermal ablation for hepatocellular carcinoma
Osman Öcal, Kerstin Schütte, Peter Malfertheiner, et al.
Journal of Hepatology
|
July 25, 2017
Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study
Thomas Berg, Karl-Georg Simon, Stefan Mauss, et al.
Annals of Internal Medicine
|
July 18, 2012
Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial
Martin Schaefer, Rahul Sarkar, Viola Knop, et al.
Alimentary Pharmacology & Therapeutics
|
February 28, 2019
Protective effects of coffee consumption following liver transplantation for hepatocellular carcinoma in cirrhosis
Georg Wiltberger, Yan Wu, Undine Lange, et al.
Gastroenterology
|
November 5, 2013
Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: a phase IIb trial
Stefan Zeuzem, Thomas Berg, Edward Gane, et al.
Journal of Hepatology
|
November 4, 2018
A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR
Mayada Metwally, Ali Bayoumi, Manuel Romero-Gomez, et al.
European Journal of Gastroenterology & Hepatology
|
November 18, 2015
Symptoms of anxiety and depression are frequent in patients with acute hepatitis C and are not associated with disease severity
Katja Deterding, Norbert Grüner, Peter Buggisch, et al.
BMJ Open
|
September 19, 2020
Prevalence of psychoactive substance use among acutely hospitalised patients in Oslo and Moscow: a cross-sectional, observational study
Danil Gamboa, Benedicte Jørgenrud, Evgeny A Bryun, et al.
JHEP Reports : Innovation in Hepatology
|
March 27, 2023
Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial
Max Seidensticker, Osman Öcal, Kerstin Schütte, et al.
Gastroenterology
|
February 12, 2009
Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy
Thierry Poynard, Massimo Colombo, Jordi Bruix, et al.
Page
of 64
Search research articles
Search
Showing results (511-520 of 633) with videos related to
Sort By:
Page
of 64
European Journal of Radiology
|
October 8, 2023
Prognostic value of baseline MRI features in patients treated with thermal ablation for hepatocellular carcinoma
Osman Öcal, Kerstin Schütte, Peter Malfertheiner, et al.
Journal of Hepatology
|
July 25, 2017
Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study
Thomas Berg, Karl-Georg Simon, Stefan Mauss, et al.
Annals of Internal Medicine
|
July 18, 2012
Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial
Martin Schaefer, Rahul Sarkar, Viola Knop, et al.
Alimentary Pharmacology & Therapeutics
|
February 28, 2019
Protective effects of coffee consumption following liver transplantation for hepatocellular carcinoma in cirrhosis
Georg Wiltberger, Yan Wu, Undine Lange, et al.
Gastroenterology
|
November 5, 2013
Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: a phase IIb trial
Stefan Zeuzem, Thomas Berg, Edward Gane, et al.
Journal of Hepatology
|
November 4, 2018
A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR
Mayada Metwally, Ali Bayoumi, Manuel Romero-Gomez, et al.
European Journal of Gastroenterology & Hepatology
|
November 18, 2015
Symptoms of anxiety and depression are frequent in patients with acute hepatitis C and are not associated with disease severity
Katja Deterding, Norbert Grüner, Peter Buggisch, et al.
BMJ Open
|
September 19, 2020
Prevalence of psychoactive substance use among acutely hospitalised patients in Oslo and Moscow: a cross-sectional, observational study
Danil Gamboa, Benedicte Jørgenrud, Evgeny A Bryun, et al.
JHEP Reports : Innovation in Hepatology
|
March 27, 2023
Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial
Max Seidensticker, Osman Öcal, Kerstin Schütte, et al.
Gastroenterology
|
February 12, 2009
Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy
Thierry Poynard, Massimo Colombo, Jordi Bruix, et al.
Page
of 64